Exclusive

Publication

Byline

Location

USPTO Publishes Trademark 'FORWARD RISK' for Opposition

U.S., Jan. 21 -- An application to own the trademark for 'FORWARD RISK' has been filed on Dec. 13, 2023. Owner(s): FORWARD GLOBAL; 17 avenue Hoche, F-75008 PARIS, FRANCE Goods and/or Services: For... Read More


USPTO Publishes Trademark 'BORSEC' for Opposition

U.S., Jan. 21 -- An application to own the trademark for 'BORSEC' has been filed on Nov. 01, 2023. Owner(s): Romaqua Group S.A.; Carpati Street no. 46, , ROMANIA Goods and/or Services: For: Minera... Read More


USPTO Publishes Trademark 'VELA TANGO' for Opposition

U.S., Jan. 21 -- An application to own the trademark for 'VELA TANGO' has been filed on Feb. 07, 2024. Owner(s): Vermund Larsen A/S; Gøteborgvej 12, , DENMARK Goods and/or Services: For: Office fu... Read More


SCHUMER, GILLIBRAND ANNOUNCE $1.5 MILLION IN FEDERAL FUNDING ON THE WAY TO NEW ROCHELLE FOR SHELDRAKE RIVER STORMWATER IMPROVEMENT

WASHINGTON, Jan. 21 -- Sen. Kirsten Gillibrand issued the following press release: U.S. Senator Chuck Schumer and U.S. Senator Kirsten Gillibrand today announced they have delivered $1,500,000 in fed... Read More


GILLIBRAND, SCHUMER ANNOUNCE $6.3M IN FEDERAL FUNDING FOR NEW YORK CITY PROJECTS

WASHINGTON, Jan. 21 -- Sen. Kirsten Gillibrand issued the following press release: Today, U.S. Senator Kirsten Gillibrand, member of the Senate Appropriations Committee, and U.S. Senator Charles Schu... Read More


International Clinical Trial: An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07357597) titled 'An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato... Read More


International Clinical Trial: A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07357766) titled 'A Research Study to Compare Different Versions of Injectable CagriSema and Plac... Read More


International Clinical Trial: Implementing Suicide Prevention Into Primary Care in Nepal

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07362056) titled 'Implementing Suicide Prevention Into Primary Care in Nepal' on Jan. 21. Study ... Read More


International Clinical Trial: Daridorexant treatment in adults with migraine and insomnia: an exploratory study of sleep and headache outcomes

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ACTRN12626000081314) titled 'Daridorexant treatment in adults with migraine and insomnia: an explora... Read More


International Clinical Trial: A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07357740) titled 'A Research Study to Compare Two Different Versions of Injectable CagriSema in P... Read More